These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Antiherpetics and their indications]. Goudsmit J; van der Noordaa J Ned Tijdschr Geneeskd; 1983 Apr; 127(14):597-602. PubMed ID: 6304541 [No Abstract] [Full Text] [Related]
25. [Viruses and antiviral drug resistance]. Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169 [No Abstract] [Full Text] [Related]
26. Recent trends and development in antiviral chemotherapy. De Clercq E Antiviral Res; 1985; Suppl 1():11-9. PubMed ID: 2417547 [No Abstract] [Full Text] [Related]
32. Studies on increased turnover of brain mono-amines induced by experimental herpes simplex infection. Lycke E; Roos BE Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(5):695-701. PubMed ID: 4118098 [No Abstract] [Full Text] [Related]
33. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine. Nasisse MP; Guy JS; Davidson MG; Sussman W; De Clercq E Am J Vet Res; 1989 Jan; 50(1):158-60. PubMed ID: 2493210 [TBL] [Abstract][Full Text] [Related]
34. [Progress in research for new drugs against the herpes virus]. Rostkowska-Nadolska B Postepy Hig Med Dosw; 1999; 53(5):675-87. PubMed ID: 10645143 [TBL] [Abstract][Full Text] [Related]
35. Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza. Lockhart SM; Salvaggio MR; Bronze MS; Greenfield RA J Okla State Med Assoc; 2007 Oct; 100(10):388-95. PubMed ID: 18085096 [TBL] [Abstract][Full Text] [Related]
37. Towards a selective chemotherapy of virus infections. Development of bromovinyldeoxyuridine as a highly potent and selective antiherpetic drug. De Clercq E Verh K Acad Geneeskd Belg; 1986; 48(4):261-90. PubMed ID: 3024419 [No Abstract] [Full Text] [Related]